Cannabis
Maryland House Advances Cannabis Legalization Bills (High Times)
D.C. Lawmakers Approve Ban On Pre-Employment Marijuana Testing For Most Workers (Marijuana Moment)
Where does Biden’s Supreme Court nominee stand on marijuana legalization? Here’s what we found (Leafly)
Medicinal Cannabis Flower Sales Begin In Minnesota (High Times)
Virginia House Committee Kills Bill To Begin Marijuana Sales This Year (Marijuana Moment)
Rhode Island Lawmakers Introduce Cannabis Legalization Bill (High Times)
NCAA Moves To Lower Marijuana Penalties For Student Athletes And Increase THC Threshold In Drug Tests (Marijuana Moment)
Nebraska Medical Cannabis Bill Fizzles in Committee (High Times)
Get ready for the Northeast to become cannabis country (Politico)
France Moves to Begin Cultivating Medical Cannabis (High Times)
Virginia lawmakers cracking down on cannabis compound Delta-8 due to safety concerns (WAVY)
South Dakota House Rejects Marijuana Legalization Bill That Was Temporarily Revived In ‘Smoke Out’ Vote (Marijuana Moment)
Ecuador Kicks Off Medical Cannabis Production (High Times)
Washington state to require pesticide testing for adult-use cannabis products (Marijuana Business Daily)
Ohio Lawmakers Advance Bill To Allow Medical Cannabis for Autism (High Times)
Confusion over CBD for Children (Drug WarRant)
Pennsylvania Senate Committee Holds Second Marijuana Legalization Hearing As Reform Bill Is Drafted (Marijuana Moment)
Georgia Lawmakers Consider Bill to Expand Medical Pot Program (High Times)
LSD
Landmark trial compares LSD and psilocybin trips, finds few differences (New Atlas)
Mystical experiences might bridge the gap between LSD-induced “madness” and healing (PsyPost)
Magic Mushrooms
Colorado may be the next state to decriminalize ‘magic’ mushrooms (The Durango Herald)
Terminal cancer patient denied magic mushrooms after Health Canada rule change (CBC)
Psilocybin Leaps Ahead of Other Psychedelics in Trials and Studies (Lucid News)
The Plan to Reschedule Psilocybin at the UN (TalkingDrugs)
'We need emergency access': 82 Canadian professionals request psilocybin for therapy training (Vancouver Sun)
Oregonians more interested in taking psilocybin for well-being than depression or anxiety (OPB)
How Will Oregon Teach and Train Psilocybin Healers? (Filter)
Magic mushrooms, psilocybin and microdosing: Growing trend draws e-vendors, scientists (CBC)
MDMA
Can MDMA Help Heal Grief? (Lucid News)
5-MeO-DMT
Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So (Forbes)
Iboga
MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program (PR Newswire)
Novel Psychoactive Substances
PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma (Psilocybin Alpha)
Synthetic Cannabinoids
CBP Officers and Scientists Identify Two New Synthetic Cannabinoid Analogues (Homeland Security Today)
Ketamine
Dr. Bronner’s to Provide Psychedelic-Therapy as Employee Healthcare Benefit (Dr. Bronner's)
Ketamine Could Treat Alcohol Use Disorder, Study Shows (Lucid News)
Dying to Stay Alive: A Ketamine Disaster (Mad in America)
Yale researchers study ketamine as a potential treatment for depression in patients with Parkinson’s disease (Yale Daily News)
Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests (Brain and Behavior Research Foundation)
Miscellaneous
It’s Time to Start Studying the Downside of Psychedelics (VICE)
Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval (Marijuana Moment)
In Oregon, Psychedelics Regulators Confront Conflicts of Interest (VICE)
More People Are Microdosing for Mental Health. But Does It Work? (The New York Times)
The Need for an International Psychedelic Religious Survey (Psychedelics Today)
Psychedelic Therapeutics Market May Receive Federal Approval Before Marijuana Does (MarketWatch)
Staring into the Abyss: Examining Venezuela’s Drug Policies (TalkingDrugs)
Global Survey: Some Microdosing Individuals Have Altered Psychiatric Drug Dosage (Psychiatry Advisor)
How Psychedelics Will Impact Mainstream Product Development (Yahoo!)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.